← Back to Clinical Trials
Recruiting NCT05819008

NCT05819008 Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05819008
Status Recruiting
Phase
Sponsor Umeå University
Condition Traumatic Brain Injury
Study Type OBSERVATIONAL
Enrollment 350 participants
Start Date 2023-03-10
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Neuropsychological Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 350 participants in total. It began in 2023-03-10 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

For the last decades, many aspects of human life have been altered by digital technology. For health care, this have opened a possibility for patients who have difficulties travelling a long distance to a hospital to meet with their health care providers over different digital platforms. With an increased digital literacy, and an aging population often living in the countryside, far from hospitals or other health care settings, an increasing need for digitalization of meetings between patients and health care personnel is inevitable. However, neuropsychological assessment is one sort of health care not possible to directly transfer into digital form. These evaluations are most often performed with well validated tests, only to be used in a paper-pencil form with a specially trained psychologist during physical meetings. The aim of this project is to investigate whether a newly developed digital neuropsychological test battery can be used to perform remote assessments of cognitive function in patients with neurological injuries and impairments. To this date, there are no such test batteries available in the Swedish language. Mindmore (www.mindmore.com) is a test system developed in Sweden, performing neuropsychological tests on a tablet, but still with the psychologist present in the room. This system is now evolving into offering the possibility for the patient to perform the test in their own home, using their own computer or tablet. The aim of the present research project is to validate this latter system (Mindmore Distance), using the following research questions: 1. Are the tests in Mindmore Distance equivalent to traditional neuropsychological tests in patients with traumatic brain injury, stroke, multiple sclerosis, Parkinson's Disease, epilepsy, and brain tumor? 2. Can the results from Mindmore Distance be transferred into neuropsychological profiles that can be used in diagnostics for specific patient groups? 3. How do the patients experience undergoing a neuropsychological evaluation on their own compared to traditional neuropsychological assessment in a physical meeting with a psychologist?

Eligibility Criteria

Inclusion Criteria: * age 18 and above * Diagnosed with a neurological disorder or injury, alternatively under medical examination for such a diagnosis * Owns and can handle a computer with internet connection Exclusion Criteria: * Severe psychiatric disorder, such a schizophrenia, severe depression * Addiction of alcohol or other substances * Not speaker of Swedish * On sedatives, such as sleep or pain medication * Multiple neurological diagnoses * Not being able to participate in a neuropsychological examination, or to give informed consent

Contact & Investigator

Central Contact

Nils Berginström, PhD

✉ nils.berginstrom@umu.se

📞 +46(0)90-786 88 64

Principal Investigator

Nils Berginström, PhD

PRINCIPAL INVESTIGATOR

Umeå Universitet, Department of Psychology

Frequently Asked Questions

Who can join the NCT05819008 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05819008 currently recruiting?

Yes, NCT05819008 is actively recruiting participants. Contact the research team at nils.berginstrom@umu.se for enrollment information.

Where is the NCT05819008 trial being conducted?

This trial is being conducted at Umeå, Sweden.

Who is sponsoring the NCT05819008 clinical trial?

NCT05819008 is sponsored by Umeå University. The principal investigator is Nils Berginström, PhD at Umeå Universitet, Department of Psychology. The trial plans to enroll 350 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology